✦ LIBER ✦

Factors Predicting the Response to Rituximab in Indolent Lymphoma

✍ Scribed by Lee, David

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab (Mabthera™, rituxan™) in patie

✍ J. Walewski; E. Kraszewska; O. Mioduszewska; J. Romejko-Jarosińska; A. Hellmann; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 83 KB

Optimizing the Clinical Benefit of Ritux

✍ Gibson, Angelia D.; Jain, Vinay K. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB

Combined lenalidomide, low-dose dexameth

✍ Ahmadi, Tahamtan; Chong, Elise A.; Gordon, Amanda; Aqui, Nicole A.; Nasta, Sunit 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Predictive Factors for Response to Ritux

✍ Dimopoulos, Meletios A.; Anagnostopoulos, Athanasios; Zervas, Constantinos; Kyrt 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 478 KB

Two Immunoglobulin G Fragment C Receptor

✍ Weng, W.-K. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 230 KB

Factors Associated with Toxicity and Res

✍ Borghaei, Hossein; Wallace, Stephen G.; Schilder, Russell J. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 113 KB